Mersana Therapeutics
Platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives. Learn more
Launch date
Employees
Market cap
AUD400m
Enterprise valuation
AUD198m (Public information from Sep 2024)
Share price
$2.19 MRSN
Cambridge Massachusetts (HQ)
Authorizing premium user...